Empirical Wealth Management’s Biogen BIIB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-1,422
| Closed | -$330K | – | 570 |
|
|
2024
Q2 | $330K | Buy |
+1,422
| New | +$330K | 0.01% | 435 |
|
|
2024
Q1 | – | Sell |
-5,234
| Closed | -$1.35M | – | 530 |
|
|
2023
Q4 | $1.35M | Buy |
+5,234
| New | +$1.35M | 0.05% | 210 |
|
|
2023
Q3 | – | Sell |
-2,306
| Closed | -$657K | – | 467 |
|
|
2023
Q2 | $657K | Buy |
+2,306
| New | +$657K | 0.03% | 266 |
|
|
2022
Q1 | – | Sell |
-950
| Closed | -$228K | – | 501 |
|
|
2021
Q4 | $228K | Buy |
950
+92
| +11% | +$22.1K | 0.01% | 471 |
|
|
2021
Q3 | $243K | Sell |
858
-231
| -21% | -$65.4K | 0.01% | 404 |
|
|
2021
Q2 | $377K | Buy |
1,089
+348
| +47% | +$120K | 0.02% | 339 |
|
|
2021
Q1 | $207K | Sell |
741
-1,616
| -69% | -$451K | 0.02% | 368 |
|
|
2020
Q4 | $577K | Buy |
2,357
+162
| +7% | +$39.7K | 0.04% | 227 |
|
|
2020
Q3 | $623K | Buy |
2,195
+299
| +16% | +$84.9K | 0.05% | 181 |
|
|
2020
Q2 | $507K | Buy |
1,896
+382
| +25% | +$102K | 0.05% | 206 |
|
|
2020
Q1 | $479K | Buy |
+1,514
| New | +$479K | 0.05% | 189 |
|